How much are people paying for GLP1s? (2024/11)
We take another look at reports of what people are paying for GLP1s with/without insurance and everywhere in between.
We take another look at reports of what people are paying for GLP1s with/without insurance and everywhere in between.
A list of FDA approved GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, etc), for easy reference.
Reports of anxiety and suicidal reports have been reported for people after *stopping* use of GLP1s. We dig in, and weight the FDA's comments.
The outgoing Biden-Harris admin puts out a proposal on widening access to GLP1s, which we hope the incoming Trump admin will also adopt.
What happens when weight loss stalls on GLP1s? We check around the GLP1 community to see what people have figured out.
A look at the UK's growing evaluation and use of GLP1 receptor agonists -- Ozempic, Mounjaroy, Wegovy, Zepbound and more.
How does GLP1 signal the brain? We take a look at related research to try and learn more.
Newly published research explores the link between Osteoarthritis and GLP1s -- positive results that are somewhat predictable.
At ObesityWeek 2024, Viking Therapeutic showed study results on their new drug VK2735 -- 8% body weight loss at 28 days, in the highest dose.
We explore the link between blinding disease/vision loss and Semaglutide, as reported by medical research.
How long will we have to wait for generic versions of GLP1 drugs? We take a look at patent expiry dates for the most popular brands & GLP1 formulations.
After legal action by a group of compounders, the FDA is reviewing their removal of Tirzepatide (Mounjaro, Zepbound) from the shortage list.
Compounders sue FDA for removing Eli Lilly's weight loss drug from the shortage list. Does the case have legs?
Bad news that sounds like good news: FDA ends shortage Eli Lilly's GLP-1 (Tirzepatide). We'll tell you why that's bad news.
GLP1s (in particular Tirzepatide, created by Eli Lilly) have positive effects on Sleep Apnea
The current GLP1 receptor agonist boom was made possible by the work of Joel Habener, Lotte Bjerre Knudsen, and Svetlana Mojsov.
category:news
Omada is moving from virtual health into the wider field of wellness programs, enhancing their offering. We dig into what's changed.
categeory:watercooler
Novo's CEO goes to congress to testify, but not much is likely to change in the drug's pricing. We dive into some historical context.
categeory:watercooler
Ozempic face isn't real -- fast weight loss causes changes to the skin, and your face is a prime area that will change.
drug:am-133
Amgen is working on a new GLP1, entering the race -- AM-133. We dig into the trials and research and see if it's got any promise.
company:eli-lilly
Eli Lilly is developing new GLP1 drugs, and Orforglipron is one of them. It's not easy to pronounce, but it is easy to take, and easy to produce.
Scientists managed to increase the number of insulin-producing cells in a human-cell-in-mouse experiment.
category:side-effects
Do GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, Zepbound, and others) cause thyroid issues?
includes:study
Do some GLP1s have less negative side effects? They work the same, but can affect you differently -- let's look at the research.
category:news
23andMe leaves drug discovery, but embraces providing GLP1 Receptor Agonists -- emphasizing a shift to active preventative care.
includes:review
Want to get refreshed on GLP1 research into drugs like Ozempic, Wegovy, Mounjaro, Zepbound and others? Start here.
drug:amycretin
Novo has a new drug it's working on -- Amycretin. Amycretin is a dual agonist, with the *new* agonist being Amylin. Read more about it here.
category:news
What effects does GLP1 have on ADHD? It's early, but we take a look at some published research.
categeory:watercooler
Wondering what the world was doing before GLP1s? We discuss Topiramate, a popular appetite suppressant.
category:news
Is mimicking more hormones better? Let's find out -- the new GLP1 drug Retatrutide is a *triple* receptor agonist
category:news
Are GLP1 Receptor Agonists (Ozempic, Wegovy, Mounjaro, etc) primarily brain drugs?
company:eli-lilly
As the race to manufacture more GLP1 medications intensifies, Eli Lilly gets approval in China and more suppliers.